Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Luís O. Sarian"'
Autor:
Marcella R. Cardoso, Alex Ap. Rosini Silva, Maria Cecília R. Talarico, Pedro H. Godoy Sanches, Maurício L. Sforça, Silvana A. Rocco, Luciana M. Rezende, Melissa Quintero, Tassia B. B. C. Costa, Laís R. Viana, Rafael R. Canevarolo, Amanda C. Ferracini, Susana Ramalho, Junier Marrero Gutierrez, Fernando Guimarães, Ljubica Tasic, Alessandra Tata, Luís O. Sarian, Leo L. Cheng, Andreia M. Porcari, Sophie F. M. Derchain
Publikováno v:
Cancers; Volume 14; Issue 20; Pages: 5055
Neoadjuvant chemotherapy (NACT) is offered to patients with operable or inoperable breast cancer (BC) to downstage the disease. Clinical responses to NACT may vary depending on a few known clinical and biological features, but the diversity of respon
Autor:
Patrick N. Pereira, Luis O. Sarian, Adriana Yoshida, Karla G. Araújo, Ricardo H. O. Barros, Ana C. Baião, Daniella B. Parente, Sophie Derchain
Publikováno v:
Diagnostic and Interventional Radiology, Vol 24, Iss 2, Pp 63-71 (2018)
PURPOSE:We aimed to evaluate the ADNEX MR scoring system for the prediction of adnexal mass malignancy, using a simplified magnetic resonance imaging (MRI) protocol.METHODS:In this prospective study, 200 patients with 237 adnexal masses underwent MRI
Externí odkaz:
https://doaj.org/article/10a53e31101941428305a1250def5705
Autor:
Raquel M. Rodrigues‐Peres, Benilton de S.Carvalho, Meenakshi Anurag, Jonathan T. Lei, Livia Conz, Rodrigo Gonçalves, Cássio Cardoso Filho, Susana Ramalho, Geisilene R. dePaiva, Sophie F. M. Derchain, Iscia Lopes‐Cendes, Matthew J. Ellis, Luis O. Sarian
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 7, Iss 7, Pp n/a-n/a (2019)
Abstract Background As the most incident tumor among women worldwide, breast cancer is a heterogeneous disease. Tremendous efforts have been made to understand how tumor characteristics as histological type, molecular subtype, and tumor microenvironm
Externí odkaz:
https://doaj.org/article/8c34c93c60204e76b242f52aaca04ef8